Proteomics in aortic aneurysm - What have we learnt so far?

Proteomics - Clinical Applications

Volumn 7, Issue 7-8, 2013, Pages 504-515

  Abdulkareem, Nada ^a   Skroblin, Philipp ^b   Jahangiri, Marjan ^a   Mayr, Manuel ^b  

^a ST GEORGE'S UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Aortic aneurysm; Biomarkers; Clinical complications

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; LOSARTAN; MATRIX METALLOPROTEINASE; PEROXIREDOXIN 1; THROMBOSPONDIN 1; TISSUE INHIBITOR OF METALLOPROTEINASE; VITAMIN D BINDING PROTEIN;

ABDOMINAL AORTA ANEURYSM; AORTA ANEURYSM; AORTA ATHEROSCLEROSIS; AORTA DILATATION; AORTA DISSECTION; AORTA RUPTURE; AORTA VALVE DISEASE; ASCENDING AORTA; ASCENDING AORTA ANEURYSM; BICUSPID AORTIC VALVE; EARLY DIAGNOSIS; EXTRACELLULAR MATRIX; HUMAN; MACROPHAGE; MARFAN SYNDROME; MONOCYTE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEOMICS; REVIEW; TRICUSPID AORTIC VALVE;

AORTIC ANEURYSM; BIOMARKERS; CLINICAL COMPLICATIONS;

ANIMALS; AORTIC ANEURYSM; BIOLOGICAL MARKERS; EXTRACELLULAR MATRIX; HUMANS; PROTEOMICS; THROMBOSIS;

EID: 84881503112     PISSN: 18628346     EISSN: 18628354     Source Type: Journal    
DOI: 10.1002/prca.201300016     Document Type: Review

References (109)

1. Elefteriades, J. A., Indications for aortic replacement. J. Thorac. Cardiovasc. Surg. 2010, 140, 5-9.
2. Booher, A. M., Isselbacher, E. M., Nienaber, C. A., Froehlich, J. B. et al., Ascending thoracic aorta dimension and outcomes in acute type B dissection (from the International Registry of Acute Aortic Dissection [IRAD]). Am. J. Cardiol. 2011, 107, 315-320.
3. Rizzo, J. A., Coady, M. A., Elefteriades, J. A., Procedures for estimating growth rates in thoracic aortic aneurysms. J. Clin. Epidemiol. 1998, 51, 747-754.
4. Elefteriades, J. A., Thoracic aortic aneurysm: reading the enemy's playbook. Curr. Probl. Cardiol. 2008, 33, 203-277.
5. Borges, L. F., Gomez, D., Quintana, M., Touat, Z. et al., Fibrinolytic activity is associated with presence of cystic medial degeneration in aneurysms of the ascending aorta. Histopathology 2010, 57, 917-932.
6. Touat, Z., Lepage, L., Ollivier, V., Nataf, P. et al., Dilation-dependent activation of platelets and prothrombin in human thoracic ascending aortic aneurysm. Arterioscler. Thromb. Vasc. Biol. 2008, 28, 940-946.
7. Bonderman, D., Gharehbaghi-Schnell, E., Wollenek, G., Maurer, G. et al., Mechanisms underlying aortic dilatation in congenital aortic valve malformation. Circulation 1999, 99, 2138-2143.
8. Lindsay, M. E., Dietz, H. C., Lessons on the pathogenesis of aneurysm from heritable conditions. Nature 2011, 473, 308-316.
9. Attias, D., Stheneur, C., Roy, C., Collod-Beroud, G. et al., Comparison of clinical presentations and outcomes between patients with TGFBR2 and FBN1 mutations in Marfan syndrome and related disorders. Circulation 2009, 120, 2541-2549.
10. Disabella, E., Grasso, M., Gambarin, F. I., Narula, N. et al., Risk of dissection in thoracic aneurysms associated with mutations of smooth muscle alpha-actin 2 (ACTA2). Heart 2011, 97, 321-326.
11. Callewaert, B., Malfait, F., Loeys, B., De Paepe, A., Ehlers-Danlos syndromes and Marfan syndrome. Best Pract. Res. Clin. Rheumatol. 2008, 22, 165-189.
12. Baetens, M., Van Laer, L., De Leeneer, K., Hellemans, J. et al., Applying massive parallel sequencing to molecular diagnosis of Marfan and Loeys-Dietz syndromes. Hum. Mutat. 2011, 32, 1053-1062.
13. Hoffman, J. I. E., Kaplan, S., The incidence of congenital heart disease. J. Am. Coll. Cardiol. 2002, 39, 1890-1900.
14. McBride, K. L., Pignatelli, R., Lewin, M., Ho, T. et al., Inheritance analysis of congenital left ventricular outflow tract obstruction malformations: segregation, multiplex relative risk, and heritability. Am. J. Med. Genet. A. 2005, 134A, 180-186.
15. Kasama, K., Ogino, H., Matsuda, H., Minatoya, K. et al., Ascending aortic aneurysm associated with a quadricuspid aortic valve. Gen. Thorac. Cardiovasc. Surg. 2011, 59, 179-180.
16. Brady, A. R., Thompson, S. G., Fowkes, F. G. R., Greenhalgh, R. M. et al., Abdominal aortic aneurysm expansion. Circulation 2004, 110, 16-21.
17. Lopez-Candales, A., Holmes, D. R., Liao, S., Scott, M. J. et al., Decreased vascular smooth muscle cell density in medial degeneration of human abdominal aortic aneurysms. Am. J. Path. 1997, 150, 993-1007.
18. Das, G., Cardiovascular effects of cocaine abuse. Int. J. Clin. Pharmacol. Ther. Toxicol. 1993, 31, 521-528.
19. Kojima, N., Sakano, Y., Ohki, S., Misawa, Y., Rapidly growing aortic arch aneurysm in Behcet's disease. Interact. Cardiovasc. Thorac. Surg. 2011, 12, 502-504.
20. Umeda, Y., Mori, Y., Takagi, H., Iwata, H. et al., Abdominal aortic aneurysm related to Takayasu arteritis during pregnancy. Heart Vessels 2004, 19, 155-156.
21. Kawamura, A., Kato, W., Araki, Y., Oshima, H. et al., Surgical treatment of ruptured aneurysm of the left sinus of Valsalva caused by Takayasu arteritis. Ann. Thorac. Surg. 2010, 90, e91-2.
22. Rajab, T. K., Gallegos, R. P., Images in clinical medicine. Giant syphilitic aortic aneurysm. N. Engl. J. Med. 2011, 364, 1258.
23. Bendermacher, B. L., Peppelenbosch, A. G., Daemen, J. W., Oude Lashof, A. M. et al., Q fever (Coxiella burnetii) causing an infected thoracoabdominal aortic aneurysm. J. Vasc. Surg. 2011, 53, 1402-1404.
24. Kotelis, D., Geisbusch, P., Hakimi, M., Bockler, D., Thoracic aortic aneurysm. Chirurg 2012, 83, 395-405.
25. Kuzmik, G. A., Sang, A. X., Elefteriades, J. A., Natural history of thoracic aortic aneurysms. J. Vasc. Surg. 2012, 56, 565-571.
26. Dapunt, O. E., Galla, J. D., Sadeghi, A. M., Lansman, S. L. et al., The natural history of thoracic aortic aneurysms. J. Thorac. Cardiovasc. Surg. 1994, 107, 1323-1332.
27. Vaidyanathan, B., Role of beta-blockers in Marfan's syndrome and bicuspid aortic valve: a time for re-appraisal. Ann. Ped. Cardiol. 2008, 1, 149-152.
28. Habashi, J. P., Doyle, J. J., Holm, T. M., Aziz, H. et al., Angiotensin II type 2 receptor signaling attenuates aortic aneurysm in mice through ERK antagonism. Science 2011, 332, 361-365.
29. Habashi, J. P., Judge, D. P., Holm, T. M., Cohn, R. D. et al., Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 2006, 312, 117-121.
30. Yang, H. H., Kim, J. M., Chum, E., van Breemen, C. et al., Effectiveness of combination of losartan potassium and doxycycline versus single-drug treatments in the secondary prevention of thoracic aortic aneurysm in Marfan syndrome. J. Thorac. Cardiovasc. Surg. 2010, 140, 305-312.
31. Gambarin, F. I., Favalli, V., Serio, A., Regazzi, M. et al., Rationale and design of a trial evaluating the effects of losartan vs. nebivolol vs. the association of both on the progression of aortic root dilation in Marfan syndrome with FBN1 gene mutations. J. Cardiovasc. Med. (Hagerstown) 2009, 10, 354-362.
32. Kim, G. S., Ahn, H. J., Kim, W. H., Kim, M. J. et al., Risk factors for postoperative complications after open infrarenal abdominal aortic aneurysm repair in Koreans. Yonsei Med. J. 2011, 52, 339-346.
33. Brewster, D. C., Cronenwett, J., Hallett, J., Johnston, K. et al., Guidelines for the treatment of abdominal aortic aneurysms. J. Vasc. Surg. 2003, 37, 1106-1117.
34. Brewster, L. P., Kasirajan, K., Thoracic endovascular aneurysm repair for thoracic aneurysms: what we know, what to expect. Ann. Vasc. Surg. 2011, 25, 856-865.
35. De Mozzi, P., Longo, U. G., Galanti, G., Maffulli, N., Bicuspid aortic valve: a literature review and its impact on sport activity. Br. Med. Bull. 2008, 85, 63-85.
36. Nienaber, C. A., Eagle, K. A., Aortic dissection: new frontiers in diagnosis and management: part I: from etiology to diagnostic strategies. Circulation 2003, 108, 628-635.
37. Nienaber, C. A., Eagle, K. A., Aortic dissection: new frontiers in diagnosis and management part II: therapeutic management and follow-up. Circulation 2003, 108, 772-778.
38. Lim, Z. S., Vettukattil, J. J., Role of echocardiography in the assessment of adolescents and adults with congenital heart disease. Minerva Cardioangiol. 2009, 57, 389-413.
39. Castañer, E., Andreu, M., Gallardo, X., Mata, J. M. et al., CT in nontraumatic acute thoracic aortic disease: typical and atypical features and complications. Radiographics 2003, 23, 93-110.
40. Ferket, B. S., Grootenboer, N., Colkesen, E. B., Visser, J. J. et al., Systematic review of guidelines on abdominal aortic aneurysm screening. J. Vasc. Surg. 2012, 55, 1296-1304.
41. Ranasinghe, A. M., Bonser, R. S., Biomarkers in acute aortic dissection and other aortic syndromes. J. Am. Coll. Cardiol. 2010, 56, 1535-1541.
42. Antoniou, G. A., Tentes, I. K., Antoniou, S. A., Georgiadis, G. S. et al., Circulating matrix metalloproteinases and their inhibitors in inguinal hernia and abdominal aortic aneurysm. Int. Angiol. 2011, 30, 123-129.
43. Fedak, P. W., de Sa, M. P., Verma, S., Nili, N. et al., Vascular matrix remodeling in patients with bicuspid aortic valve malformations: implications for aortic dilatation. J Thorac. Cardiovasc. Surg. 2003, 126, 797-806.
44. Wilton, E., Bland, M., Thompson, M., Jahangiri, M., Matrix metalloproteinase expression in the ascending aorta and aortic valve. Interact. Cardiovasc. Thorac. Surg. 2008, 7, 37-40.
45. Lindholt, J., Vammen, S., Fasting, H., Henneberg, E. et al., The plasma level of matrix metalloproteinase 9 may predict the natural history of small abdominal aortic aneurysms. A preliminary study. Eur. J. Vasc. Endovasc. Surg. 2000, 20, 281-285.
46. Karapanagiotidis, G. T., Antonitsis, P., Charokopos, N., Foroulis, C. N. et al., Serum levels of matrix metalloproteinases-1, -2, -3 and-9 in thoracic aortic diseases and acute myocardial ischemia. J. Cardiothorac. Surg. 2009, 4, 59.
47. Payne, J. B., Golub, L. M., Stoner, J. A., Lee, H. M. et al., The effect of subantimicrobial-dose-doxycycline periodontal therapy on serum biomarkers of systemic inflammation: a randomized, double-masked, placebo-controlled clinical trial. J. Am. Dent. Assoc. 2011, 142, 262-273.
48. Wallinder, J., Bergström, J., Henriksson, A. E., Discovery of a novel circulating biomarker in patients with abdominal aortic aneurysm: a pilot study using a proteomic approach. Clin. Transl. Sci. 2012, 5, 56-59.
49. Nordon, I. M., Brar, R., Hinchliffe, R. J., Cockerill, G. et al., Proteomics and pitfalls in the search for potential biomarkers of abdominal aortic aneurysms. Vascular 2010, 18, 264-268.
50. Urbonavicius, S., Urbonaviciene, G., Honore, B., Henneberg, E. et al., Potential circulating biomarkers for abdominal aortic aneurysm expansion and rupture-a systematic review. Eur. J. Vasc. Endovasc. Surg. 2008, 36, 273-280.
51. Wen, D., Zhou, X. L., Li, J. J., Hui, R. T., Biomarkers in aortic dissection. Clin. Chim. Acta 2011, 412, 688-695.
52. Farkas, E. A., Biomarkers for diagnosis in thoracic aortic disease: CON. Cardiol. Clin. 2010, 28, 213-220.
53. Gamberi, T., Puglia, M., Guidi, F., Magherini, F. et al., A proteomic approach to identify plasma proteins in patients with abdominal aortic aneurysm. Mol. BioSyst. 2011, 7, 2855-2862.
54. Spadaccio, C., Di Domenico, F., Perluigi, M., Lusini, M. et al., Serum proteomics in patients with diagnosis of abdominal aortic aneurysm. Cardiovasc. Pathol. 2011, 21, 283-290.
55. Acosta-Martin, A. E., Panchaud, A., Chwastyniak, M., Dupont, A. et al., Quantitative mass spectrometry analysis using PAcIFIC for the identification of plasma diagnostic biomarkers for abdominal aortic aneurysm. PloS One 2011, 6, e28698.
56. Chun, R. F., New perspectives on the vitamin D binding protein. Cell Biochem. Funct. 2012, 30, 445-456.
57. Anderson, N. L., Anderson, N. G., The human plasma proteome history, character, and diagnostic prospects. Mol. Cell. Proteomics 2002, 1, 845-867.
58. Mustafa, S. A., Hoheisel, J. D., Alhamdani, M. S. S., Secretome profiling with antibody microarrays. Mol. BioSyst. 2011, 7, 1795-1801.
59. Middleton, R. K., Lloyd, G. M., Bown, M. J., Cooper, N. J. et al., The pro-inflammatory and chemotactic cytokine microenvironment of the abdominal aortic aneurysm wall: a protein array study. J. Vasc. Surg. 2007, 45, 574-580.
60. Golledge, J., Clancy, P., Moran, C., Biros, E. et al., The novel association of the chemokine CCL22 with abdominal aortic aneurysm. Am. J. Pathol. 2010, 176, 2098-2106.
61. Ramos-Mozo, P., Rodriguez, C., Pastor-Vargas, C., Blanco-Colio, L. et al., Plasma profiling by a protein array approach identifies IGFBP-1 as a novel biomarker of abdominal aortic aneurysm. Atherosclerosis 2012, 221, 544-550.
62. Lamblin, N., Ratajczak, P., Hot, D., Dubois, E. et al., Profile of macrophages in human abdominal aortic aneurysms: a transcriptomic, proteomic, and antibody protein array study. J. Proteome Res. 2010, 9, 3720-3729.
63. Addona, T. A., Shi, X., Keshishian, H., Mani, D. et al., A pipeline that integrates the discovery and verification of plasma protein biomarkers reveals candidate markers for cardiovascular disease. Nat. Biotechnol. 2011, 29, 635-643.
64. Rizas, K. D., Ippagunta, N., Tilson, III, M. D., Immune cells and molecular mediators in the pathogenesis of the abdominal aortic aneurysm. Cardiol. Rev. 2009, 17, 201-210.
65. Ramos-Mozo, P., Madrigal-Matute, J., Martinez-Pinna, R., Blanco-Colio, L. M. et al., Proteomic analysis of polymorphonuclear neutrophils identifies catalase as a novel biomarker of abdominal aortic aneurysm: potential implication of oxidative stress in abdominal aortic aneurysm progression. Arterioscler. Thromb. Vasc. Biol. 2011, 31, 3011-3019.
66. Martinez-Pinna, R., Ramos-Mozo, P., Madrigal-Matute, J., Blanco-Colio, L. M. et al., Identification of peroxiredoxin-1 as a novel biomarker of abdominal aortic aneurysm. Arterioscler. Thromb. Vasc. Biol. 2011, 31, 935-943.
67. Moxon, J. V., Padula, M. P., Clancy, P., Emeto, T. I. et al., Proteomic analysis of intra-arterial thrombus secretions reveals a negative association of clusterin and thrombospondin-1 with abdominal aortic aneurysm. Atherosclerosis 2011, 219, 432-439.
68. Dejouvencel, T., Féron, D., Rossignol, P., Sapoval, M. et al., Hemorphin 7 reflects hemoglobin proteolysis in abdominal aortic aneurysm. Arterioscler. Thromb. Vasc. Biol. 2010, 30, 269-275.
69. Urbonavicius, S., Lindholt, J. S., Delbosc, S., Urbonaviciene, G. et al., Proteins associated with the size and expansion rate of the abdominal aortic aneurysm wall as identified by proteomic analysis. Inter. CardioVasc. Thorac. Surg. 2010, 11, 433-441.
70. Nordon, I. M., Hinchliffe, R. J., Malkawi, A. H., Pirianov, G. et al., Comparative proteomics reveals a systemic vulnerability in the vasculature of patients with abdominal aortic aneurysms. J. Vasc. Surg. 2011, 6, 1100-1108.
71. Urbonavicius, S., Lindholt, J. S., Vorum, H., Urbonaviciene, G. et al., Proteomic identification of differentially expressed proteins in aortic wall of patients with ruptured and nonruptured abdominal aortic aneurysms. J. Vasc. Surg. 2009, 49, 455-463.
72. Ando, T., Nagai, K., Chikada, M., Okamoto, K. et al., Proteomic analyses of aortic wall in patients with abdominal aortic aneurysm. J. Cardiovasc. Surg. (Torino) 2011, 52, 545-555.
73. Didangelos, A., Yin, X., Mandal, K., Saje, A. et al., Extracellular matrix composition and remodeling in human abdominal aortic aneurysms: a proteomics approach. Mol. Cell Proteom. 2011, 10, 2048-2062.
74. Modrego, J., López-Farré, A. J., Martínez-López, I., Muela, M. et al., Expression of cytoskeleton and energetic metabolism-related proteins at human abdominal aortic aneurysm sites. J. Vasc. Surg. 2012, 55, 1124-1133.
75. Matt, P., Fu, Z., Carrel, T., Huso, D. L. et al., Proteomic alterations in heat shock protein 27 and identification of phosphoproteins in ascending aortic aneurysm associated with bicuspid and tricuspid aortic valve. J. Mol. Cell. Cardiol. 2007, 43, 792-801.
76. Pilop, C., Aregger, F., Gorman, R. C., Brunisholz, R. et al., Proteomic analysis in aortic media of patients with Marfan syndrome reveals increased activity of calpain 2 in aortic aneurysms. Circulation 2009, 120, 983-991.
77. Modrego, J., Monux, G., Mateos-Caceres, P. J., Martinez-Lopez, I. et al., Effects of platelets on the protein expression in aortic segments: a proteomic approach. J. Cell. Biochem. 2010, 111, 889-898.
78. Schachner, T., Golderer, G., Sarg, B., Lindner, H. H. et al., The amounts of alpha 1 antitrypsin protein are reduced in the vascular wall of the acutely dissected human ascending aorta. Eur. J. Cardiothorac. Surg. 2010, 37, 684-690.
79. Kjellqvist, S., Maleki, S., Olsson, T., Chwastyniak, M. et al., A combined proteomic and transcriptomic approach shows diverging molecular mechanisms in thoracic aortic aneurysm development in patients with tricuspid-and bicuspid aortic valve. Mol. Cell Proteom. 2012, 26, 407-425.
80. Matt, P., von Orelli, A., Bernet, F., Grussenmeyer, T. et al., Proteomics of ascending aortic aneurysm with bicuspid or tricuspid aortic valve. Asian Cardiovasc. Thorac. Ann. 2007, 15, 185-190.
81. Tsui, J. C., Experimental models of abdominal aortic aneurysms. Open Cardiovasc. Med. J. 2010, 4, 221-230.
82. Moxon, J. V., Parr, A., Emeto, T. I., Walker, P. et al., Diagnosis and monitoring of abdominal aortic aneurysm: current status and future prospects. Curr. Probl. Cardiol. 2010, 35, 512-548.
83. Humphrey, J. D., Cardiovascular Solid Mechanics: Cells, Tissues, and Organs. Springer Verlag, New York 2002.
84. Didangelos, A., Yin, X., Mandal, K., Baumert, M. et al., Proteomics characterization of extracellular space components in the human aorta. Mol. Cell Proteom. 2010, 9, 2048-2062.
85. Didangelos, A., Yin, X., Mayr, M., Method for protein subfractionation of cardiovascular tissues before DIGE analysis. Methods Mol. Biol. 2012, 854, 287-297.
86. Stegemann, C., Didangelos, A., Barallobre-Barreiro, J., Langley, S. et al., Proteomic identification of matrix metalloproteinase substrates in the human vasculature. Circ Cardiovasc Genet. 2013, 6, 106-117.
87. Schildmeyer, L., Braun, R., Taffet, G., Debiasi, M. et al., Impaired vascular contractility and blood pressure homeostasis in the smooth muscle α-actin null mouse. FASEB J. 2000, 14, 2213-2220.
88. Oh, S. P., Seki, T., Goss, K. A., Imamura, T. et al., Activin receptor-like kinase 1 modulates transforming growth factor-β1 signaling in the regulation of angiogenesis. Proc. Natl. Acad. Sci. U S A. 2000, 97, 2626-2631.
89. Rahkonen, O., Su, M., Hakovirta, H., Koskivirta, I. et al., Mice with a deletion in the first intron of the Col1a1 gene develop age-dependent aortic dissection and rupture. Circ. Res. 2004, 94, 83-90.
90. Liu, X., Wu, H., Byrne, M., Krane, S. et al., Type III collagen is crucial for collagen I fibrillogenesis and for normal cardiovascular development. J. Biol. Chem. 1997, 94, 1852-1856.
91. Kashtan, C. E., Segal, Y., Flinter, F., Makanjuola, D. et al., Aortic abnormalities in males with Alport syndrome. Nephrol. Dial. Transplant. 2010, 25, 3554-3560.
92. Huang, J., Davis, E. C., Chapman, S. L., Budatha, M. et al., Fibulin-4 deficiency results in ascending aortic aneurysms a potential link between abnormal smooth muscle cell phenotype and aneurysm progression. Circ. Res. 2010, 106, 583-592.
93. Li, D. Y., Brooke, B., Davis, E. C., Mecham, R. P. et al., Elastin is an essential determinant of arterial morphogenesis. Nature 1998, 393, 276-280.
94. Arthur, H. M., Ure, J., Smith, A. J. H., Renforth, G. et al., Endoglin, an ancillary TGFβ receptor, is required for extraembryonic angiogenesis and plays a key role in heart development. Dev. Biol. 2000, 217, 42-53.
95. Carta, L., Pereira, L., Arteaga-Solis, E., Lee-Arteaga, S. Y. et al., Fibrillins 1 and 2 perform partially overlapping functions during aortic development. J. Biol. Chem. 2006, 281, 8016-8023.
96. Feng, Y., Chen, M. H., Moskowitz, I. P., Mendonza, A. M. et al., Filamin A (FLNA) is required for cell-cell contact in vascular development and cardiac morphogenesis. Proc. Natl. Acad. Sci. U S A. 2006, 103, 19836-19841.
97. Xue, Y., Gao, X., Lindsell, C. E., Norton, C. R. et al., Embryonic lethality and vascular defects in mice lacking the Notch ligand Jagged1. Hum. Mol. Genet. 1999, 8, 723-730.
98. Morano, I., Chai, G. X., Baltas, L. G., Lamounier-Zepter, V. et al., Smooth-muscle contraction without smooth-muscle myosin. Nat. Cell Biol. 2000, 2, 371-375.
99. Zhou, L., Liu, Y., Lu, L., Lu, X. et al., Cardiac gene activation analysis in mammalian non-myoblasic cells by Nkx2-5, Tbx5, Gata4 and Myocd. PLoS One 2012, 7, e48028.
100. Garg, V., Muth, A. N., Ransom, J. F., Schluterman, M. K. et al., Mutations in NOTCH1 cause aortic valve disease. Nature 2005, 437, 270-274.
101. Takaluoma, K., Hyry, M., Lantto, J., Sormunen, R. et al., Tissue-specific changes in the hydroxylysine content and cross-links of collagens and alterations in fibril morphology in lysyl hydroxylase 1 knock-out mice. J. Biol. Chem. 2007, 282, 6588-6596.
102. Araki, T., Mohi, M. G., Ismat, F. A., Bronson, R. T. et al., Mouse model of Noonan syndrome reveals cell type and gene dosage-dependent effects of Ptpn11 mutation. Nat. Med. 2004, 10, 849-857.
103. Cheng, C. H., Kikuchi, T., Chen, Y. H., Sabbagha, N. G. A. A. A. et al., Mutations in the SLC2A10 gene cause arterial abnormalities in mice. Cardiovasc. Res. 2009, 81, 381-388.
104. Lu, P., Wang, S., Cai, W., Sheng, J., Role of TGF-β1/Smad3 signaling pathway in secretion of type I and III collagen by vascular smooth muscle cells of rats undergoing balloon injury. J. Biomed. Biotechnol. 2012, 2012, 965953.
105. Larsson, J., Goumans, M. J., Sjostrand, L. J., Van Rooijen, M. A. et al., Abnormal angiogenesis but intact hematopoietic potential in TGF-{beta} type I receptor-deficient mice. EMBO J. 2001, 20, 1663-1673.
106. Langlois, D., Hneino, M., Bouazza, L., Parlakian, A. et al., Conditional inactivation of TGF-β type II receptor in smooth muscle cells and epicardium causes lethal aortic and cardiac defects. Transgenic Res. 2010, 19, 1069-1082.
107. Cao, J., Gong, L., Guo, D., Mietzsch, U. et al., Thoracic aortic disease in tuberous sclerosis complex: molecular pathogenesis and potential therapies in Tsc2/- mice. Hum. Mol. Genet. 2010, 19, 1908-1920.
108. Ehsan, S., Ball, G., Choke, E., Molyneux, K. et al., Disease specific biomarkers of abdominal aortic aneurysms detected by surface enhanced laser desorption ionization time of flight mass spectrometry. Eur. J. Vasc. Endovasc. Surg. 2012, 44, 52-54.
109. Farina, A., Chambery, A., Esposito, S., Agozzino, L. et al., Proteomic profiling of medial degeneration in human ascending aorta. Clin. Biochem. 2010, 43, 387-396.